Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

How to Choose a Biotechnology Consultant for Your Business

May 22, 2025

Understanding the Role of a Biotechnology Consultant

In the fast-evolving landscape of biotechnology, having a consultant can be invaluable for businesses seeking to innovate and grow. A biotechnology consultant offers expertise in areas such as regulatory compliance, product development, and strategic planning. They can guide companies through complex processes and help them make informed decisions that align with industry standards.

biotechnology consultant

Identifying Your Business Needs

Before selecting a consultant, it's crucial to clearly identify the specific needs of your business. Are you looking for help with regulatory submissions, or do you need strategic advice for entering new markets? Understanding these needs will help you find a consultant whose expertise aligns with your goals. Consider creating a checklist to prioritize your requirements and refine your search criteria.

Moreover, assess whether the consultant can offer a fresh perspective on existing challenges. Sometimes an external viewpoint can reveal opportunities and risks that internal teams might overlook. This clarity can be instrumental in steering your business in the right direction.

Evaluating Experience and Expertise

When choosing a biotechnology consultant, their experience and expertise should be top priorities. Look for consultants with a proven track record in your specific area of interest. Check their past projects and client testimonials to gauge their capability and reliability. Additionally, verify their educational background and any certifications that demonstrate a commitment to staying current in the field.

biotechnology research

Experience in navigating regulatory landscapes is often critical, especially if your business operates in highly regulated areas such as pharmaceuticals or medical devices. A consultant with this expertise can help expedite processes and ensure compliance with all relevant regulations.

Assessing Communication Skills

Effective communication is key to a successful partnership with a biotechnology consultant. Ensure they can convey complex scientific concepts in an understandable way, facilitating better decision-making within your team. Good consultants are not just experts; they are also educators who can empower your team with knowledge.

During initial meetings, pay attention to how they communicate their ideas and whether they listen actively to your concerns and goals. This interaction will set the tone for your ongoing collaboration.

business communication

Considering Cost and Value

While cost is an important factor, it should not be the sole determining factor when choosing a biotechnology consultant. Instead, focus on the value they bring to your business. Consider how their expertise could lead to cost savings, improved efficiency, or increased revenue over time.

Discuss pricing structures upfront to avoid any surprises later. Some consultants charge flat rates, while others may bill hourly or project-based. Evaluate which model aligns best with your budget and expected project outcomes.

Checking References and Building Relationships

Before finalizing your decision, request references from previous clients. This step offers insights into the consultant's reliability, work ethic, and effectiveness in achieving desired results. Speak directly with these references to get a holistic view of what it's like to work with the consultant.

Building a strong working relationship with your consultant is vital. Establish clear communication channels and set expectations from the outset to ensure a smooth collaboration. A mutually respectful relationship enhances productivity and fosters a positive working environment.

business partnership